Clinical Trial Update: The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial [Phase 4]

View source ↗

Summary

This document reports the completion of the Phase 4 MetCAB trial evaluating metformin in patients undergoing coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Ischemic Heart Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Cardiovascular Disease, Ischemic Heart Disease | Phase 4 | Status: COMPLETED